Eosinophilic Driven Diseases Management Forum
Eosinophilic Driven Diseases Management Forum
Nucala is now approved in 4 indications in Saudi Arabia and the objective of the meeting is to raise Saudi HCPs awareness about the management of Eosinophilic Driven Diseases 1
Speakers
Dr. Hussain Juwaid
Head of Severe Asthma and Airway Diseases Unit, Consultant of Chest and Sleep Medicine at Prince Sultan Medical Military City.
Dr. Hajar Al-Hayyan
Pulmonary Consultant King Saud bin Abdulaziz University National Guard Hospital, Riyadh
Dr. Tariq Tatwani MD, FRCS
Rhinologist Skull base Surgeon, Prince Sultan Military Medical City
Prof. Emilio Pizzichini
Global Medical Expert, GSK Works at University Hospital of UFSC (Federal University of Santa Catarina), Florianopolis, Santa Catarina –Brazil. Professor of Respiratory Medicine and Head of the Asthma and Airway Inflammation Centre (NUPAIVA) at the Universidad Federal de Santa Catarina in Florianópolis, Brazil.
Agenda
21:00 - 21:10 - Welcoming & introduction
21:10 - 21:30 - Severe Asthma Diagnoses, Comorbidities and Management.
21:30 - 21:50: Chronic Rhinosinusitis and the Role of Biologics.
21:50 - 22:10 - Mepolizumab Overview in Severe Asthma Management and CRSwNP.
22:10 - 22:30 - Q & A.
Trademarks are owned by or licensed to the GSK group of companies.
This Event is organized by GSK in collaboration with the Saudi Society of Internal Medicine and intended for healthcare professionals in Saudi Arabia only.
PM-SA-MPL-WCNT-220001
Date of preparation February 2022